230 related articles for article (PubMed ID: 24074231)
1. A molecular connection of Pterocarpus marsupium, Eugenia jambolana and Gymnema sylvestre with dipeptidyl peptidase-4 in the treatment of diabetes.
Kosaraju J; Dubala A; Chinni S; Khatwal RB; Satish Kumar MN; Basavan D
Pharm Biol; 2014 Feb; 52(2):268-71. PubMed ID: 24074231
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
Kosaraju J; Madhunapantula SV; Chinni S; Khatwal RB; Dubala A; Muthureddy Nataraj SK; Basavan D
Behav Brain Res; 2014 Jul; 267():55-65. PubMed ID: 24667360
[TBL] [Abstract][Full Text] [Related]
3. Complementary and comparative study on hypoglycemic and antihyperglycemic activity of various extracts of Eugenia jambolana seed, Momordica charantia fruits, Gymnema sylvestre, and Trigonella foenum graecum seeds in rats.
Yadav M; Lavania A; Tomar R; Prasad GB; Jain S; Yadav H
Appl Biochem Biotechnol; 2010 Apr; 160(8):2388-400. PubMed ID: 19904502
[TBL] [Abstract][Full Text] [Related]
4. DPP-IV inhibitory potential of naringin: an in silico, in vitro and in vivo study.
Parmar HS; Jain P; Chauhan DS; Bhinchar MK; Munjal V; Yusuf M; Choube K; Tawani A; Tiwari V; Manivannan E; Kumar A
Diabetes Res Clin Pract; 2012 Jul; 97(1):105-11. PubMed ID: 22410395
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the anti-diabetic activity of Pterocarpus marsupium Roxb. heartwood in alloxan induced diabetic rats using extracts obtained by optimized conventional and non conventional extraction methods.
Devgan M; Nanda A; Ansari SH
Pak J Pharm Sci; 2013 Sep; 26(5):973-6. PubMed ID: 24035955
[TBL] [Abstract][Full Text] [Related]
6. The relationship between anagliptin concentration showing over 80% inhibition of plasma dipeptidyl peptidase-4 activity and its protective effect against glucagon-like peptide-1 degradation.
Furuta S; Goto M; Tamura M; Yamashita S; Nakaya K; Furuta Y
Drug Res (Stuttg); 2014 Mar; 64(3):130-5. PubMed ID: 23965798
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys.
Lee B; Shi L; Kassel DB; Asakawa T; Takeuchi K; Christopher RJ
Eur J Pharmacol; 2008 Jul; 589(1-3):306-14. PubMed ID: 18538760
[TBL] [Abstract][Full Text] [Related]
8. Hypogylcemic activity of aqueous extract of some indigenous plants.
Khan B; Arayne MS; Naz S; Mukhtar N
Pak J Pharm Sci; 2005 Jan; 18(1):62-4. PubMed ID: 16431387
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study.
Kim TE; Lim KS; Park MK; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Sep; 34(9):1986-98. PubMed ID: 22943970
[TBL] [Abstract][Full Text] [Related]
10. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
[TBL] [Abstract][Full Text] [Related]
11. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
Akarte AS; Srinivasan BP; Gandhi S
Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
[TBL] [Abstract][Full Text] [Related]
12. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts.
Rathi SS; Grover JK; Vikrant V; Biswas NR
Phytother Res; 2002 Dec; 16(8):774-7. PubMed ID: 12458487
[TBL] [Abstract][Full Text] [Related]
13. Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Pharmacol Rep; 2009; 61(5):899-908. PubMed ID: 19904014
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dipeptidyl peptidase activity by flavonol glycosides of guava (Psidium guajava L.): a key to the beneficial effects of guava in type II diabetes mellitus.
Eidenberger T; Selg M; Krennhuber K
Fitoterapia; 2013 Sep; 89():74-9. PubMed ID: 23707747
[TBL] [Abstract][Full Text] [Related]
16. Effects of Gymnema sylvestre extract on the pharmacokinetics and pharmacodynamics of glimepiride in streptozotocin induced diabetic rats.
Kamble B; Gupta A; Moothedath I; Khatal L; Janrao S; Jadhav A; Duraiswamy B
Chem Biol Interact; 2016 Feb; 245():30-8. PubMed ID: 26721197
[TBL] [Abstract][Full Text] [Related]
17. Possible biochemical effects following inhibition of ethanol-induced gastric mucosa damage by Gymnema sylvestre in male Wistar albino rats.
Al-Rejaie SS; Abuohashish HM; Ahmed MM; Aleisa AM; Alkhamees O
Pharm Biol; 2012 Dec; 50(12):1542-50. PubMed ID: 22978267
[TBL] [Abstract][Full Text] [Related]
18. Effect of aqueous extract of Pterocarpus marsupium wood on alloxan-induced diabetic rats.
Mukhtar HM; Ansari SH; Ali M; Bhat ZA; Naved T
Pharmazie; 2005 Jun; 60(6):478-9. PubMed ID: 15997844
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitor.
Jain MR; Joharapurkar AA; Bahekar RH; Patel H; Jadav P; Kshirsagar SG; Patel VJ; Patel KN; Ramanathan VK; Patel PR; Desai RC
J Diabetes; 2015 Sep; 7(5):708-17. PubMed ID: 25327540
[TBL] [Abstract][Full Text] [Related]
20. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
